Drug-drug Interaction Study of FYU-981 and Oxaprozin
Status:
Completed
Trial end date:
2017-12-05
Target enrollment:
Participant gender:
Summary
This is an open-label, 2-period add-on study to assess the drug-drug interaction between
FYU-981 and oxaprozin. The purpose of this study is to investigate the pharmacokinetics of
each period in a single administration of FYU-981 and concomitant administration of FYU-981
with oxaprozin at steady -state in healthy volunteers.